| [notice] |
2026년 학회 및 전시정보  |
관리자 |
2026.01.01 |
122 |
| 15 |
[Citation] Exercise-induced CLCF1 attenuates age-related muscle and bone decline in mice |
ybiologics |
2026.02.20 |
32 |
| 14 |
[논문] Antibodies to watch in 2026 |
ybiologics |
2026.02.03 |
84 |
| 13 |
[Technical Support] Affinity Service |
ybiologics |
2026.01.23 |
92 |
| 12 |
[논문] Immunogenicity risk mitigation of therapeutic proteins with translational immunogenicity, |
ybiologics |
2025.12.15 |
238 |
| 11 |
[Citation] Del-1, an Endogenous Inhibitor of TGF-β Activation, Attenuates Fibrosis |
ybiologics |
2025.11.26 |
336 |
| 10 |
[논문] Developability considerations for bispecific and multispecific antibodies |
ybiologics |
2025.11.18 |
269 |
| 9 |
[Citation] Endogenous DEL-1 restrains melanoma lung metastasis by limiting |
ybiologics |
2025.11.11 |
253 |
| 8 |
[논문] Bispecific antibodies: advancing precision oncology |
ybiologics |
2025.11.03 |
252 |
| 7 |
[Citation] Colony-stimulating factor 3 |
ybiologics |
2025.10.17 |
279 |
| 6 |
Discovery Antibody Screening Services |
ybiologics |
2025.07.23 |
539 |
| 5 |
Ymax®-NANO : A Single Domain Antibody Library |
ybiologics |
2025.06.30 |
1,543 |
| 4 |
[Service Brochure] Human Nanobody Screening |
ybiologics |
2025.01.02 |
851 |
| 3 |
[Service Brochure] Antibody Humanization |
ybiologics |
2024.11.15 |
581 |
| 2 |
[Service Brochure] Affinity Maturation |
ybiologics |
2024.11.15 |
457 |
| 1 |
[Service Brochure] Antibody Analysis Service |
ybiologics |
2024.11.15 |
488 |
